AltaBioscience attains UKAS ISO 17025:2005 accreditation for urinary steroid analysis
Alta Bioscience Ltd is pleased to announce the UKAS accreditation of its urinary steroid profiling test to ISO 17025:2005.
Alta Bioscience Ltd is pleased to announce the UKAS accreditation of its urinary steroid profiling test to ISO 17025:2005.
AltaBioscience is pleased to announce that after an application to the International Laboratory Accreditation Cooperation (ILAC), it has been confirmed that all ISO17025:2005 standards held currently, also conform to the requirements of ILAC.
AltaBioscience is pleased to announce an extension to our food testing capabilities to now include gluten/ gliadin testing.
AltaBioscience is pleased to announce the appointment of a new member of the sales team. Paul Withers joins the team as a Sales Specialist and will be your point of contact for all laboratory services requirements.
ISO 17025:2005 accreditation reaffirmed for Amino Acid Analysis and Protein Sequencing AltaBioscience is pleased to announce renewal of its accreditation to ISO 17025:2005 for amino acid analysis and N-terminal protein sequencing. This gives our customers a high level of confidence for high quality analysis. Our quality assurance to this standard means that all actions are taken to ensure that our […]
AltaBioscience is accredited by UKAS for N-terminal protein sequencing and amino acid analysis.
AltaBioscience is pleased to announce that we have once again retained our on-going conformity to 2 quality standards, ISO 17025: 2005 and ISO 9001:2008.
We are delighted to announce the renewed affirmation of two internationally recognised quality standards
A joint venture company between Abingdon Health and the University of Birmingham won ‘The Open Collaboration Award’ at the Lord Stafford Awards ceremony and dinner last night.
Alta Bioscience Ltd, a specialist contract manufacturing and analysis organization, is pleased to announce that it has won funding of £100,000 in the form of a grant from the Birmingham Post Business Growth Fund.